Author:
Nair Pranav,Nair Chithira V,Kulirankal Kiran G,Corley Elizabeth M,Edathadathil Fabia,Gutjahr Georg,Moni Merlin,Sathyapalan Dipu T
Abstract
Abstract
Background
With the World Health Organization (WHO) declaring an end to the COVID-19 pandemic, the focus has shifted to understanding and managing long-term post-infectious complications. “Long COVID,“ characterized by persistent or new onset symptoms extending beyond the initial phase of infection, is one such complication. This study aims to describe the incidence, clinical features and risk profile of long COVID among individuals in a South Indian cohort who experienced post-ChAdOx1 n-Cov-2 vaccine breakthrough infections.
Methods
A single-centre hospital-based prospective observational study was conducted from October to December 2021. The study population comprised adult patients (> 18 years) with a confirmed COVID-19 diagnosis who had received at least a single dose of vaccination. Data was collected using a specially tailored questionnaire at week 2, week 6, and week 12 post-negative COVID-19 test. A propensity score based predictive scoring system was developed to assess the risk of long COVID.
Results
Among the 414 patients followed up in the study, 164 (39.6%) reported long COVID symptoms persisting beyond 6 week’s post-infection. The presence of long COVID was significantly higher among patients above 65 years of age, and those with comorbidities such as Type II Diabetes Mellitus, hypertension, dyslipidemia, coronary artery disease, asthma, and cancer. Using backwards selection, a reduced model was developed, identifying age (OR 1.053, 95% CI 0.097–1.07, p < 0.001), hypertension (OR 2.59, 95% CI 1.46–4.59, p = 0.001), and bronchial asthma (OR 3.7176, 95% CI 1.24–11.12, p = 0.018) as significant predictors of long COVID incidence. A significant positive correlation was observed between the symptomatic burden and the number of individual comorbidities.
Conclusions
The significant presence of long COVID at 12 weeks among non-hospitalised patients underscores the importance of post-recovery follow-up to assess for the presence of long COVID. The predictive risk score proposed in this study may help identify individuals at risk of developing long COVID. Further research is needed to understand the impact of long COVID on patients’ quality of life and the potential role of tailored rehabilitation programs in improving patient outcomes.
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. WHO Declares End to COVID-19 as Global Health Emergency. https://sdg.iisd.org/news/who-declares-end-to-covid-19-as-global-health-emergency/. (accessed jul 2, 2023).
2. Yang C, Tebbutt SJ. Long COVID: the next public health crisis is already on its way. Lancet Reg Health–Europe. 2023;28.
3. Post -COVID, Conditions. Information for Health Care Providers. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html. (accessed sep 22, 2022).
4. Long COVID. terms and definitions development explained. https://www.covid.gov/longcovid/definitions. (accessed sep 23, 2022).
5. Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, Alijotas-Reig J, Zinserling V, Semenova N, Amital H, Shoenfeld Y. Covid-19 and autoimmunity. Autoimmun rev. 2020;19(8):102597.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献